Atlas Trials

A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine

Clinical trial NCT00791622 · COMPLETED

Trial details

NCT number
NCT00791622
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder
Start date
2006-01-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.